Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthetic Biology02:55

Synthetic Biology

5.1K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Subviral Agents01:29

Subviral Agents

255
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
255
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.4K
Experimental RNAi02:15

Experimental RNAi

6.6K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K
Leaky Scanning02:28

Leaky Scanning

5.3K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin topology control by a muscle-specific ribosomal protein.

bioRxiv : the preprint server for biology·2026
Same author

Pathogenicity Analysis of Two Novel CRB1 Mutations in Three Chinese Inherited Retinal Dystrophy Families and a Literature Review.

Translational vision science & technology·2026
Same author

A grading system based on multiparametric MRI-predicted tumor perfusion, invasiveness and texture (GOLDS-PIT) for surgical difficulty assessment in pituitary macroadenomas: A prospective single-centre cohort study.

World neurosurgery·2026
Same author

Association of hormone receptor-based pathological features with prognosis in high-grade serous ovarian carcinoma: a retrospective cohort study and nomogram construction.

Journal of ovarian research·2026
Same author

Spatially tailored spin wave excitation for spurious-free, low-loss magnetostatic wave filters with ultra-wide frequency tunability.

Microsystems & nanoengineering·2026
Same author

Chitin nanowhiskers based on Periplaneta americana residue for preparing deep eutectic solvent (DES)-thrombin bio-adhesive with hemostatic effect.

International journal of biological macromolecules·2026

Related Experiment Video

Updated: Oct 29, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

A synthetic defective interfering SARS-CoV-2.

Shun Yao1, Anoop Narayanan2, Sydney A Majowicz2

  • 1Department of Biology, Pennsylvania State University, University Park, United States of America.

Peerj
|July 12, 2021
PubMed
Summary

Scientists created a synthetic defective SARS-CoV-2 genome that replicates faster than the original virus. This defective genome reduces viral load by half in 24 hours, offering a potential self-promoting antiviral therapy.

Keywords:
CoronavirusCovid-19Defective Interfering ParticleSARS-CoV-2Synthetic Biology

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

779

Related Experiment Videos

Last Updated: Oct 29, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

779

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Viruses rely on host cells for replication, making them vulnerable to defective viral genomes.
  • Defective interfering particles (DIPs) can exploit and interfere with the replication of full-length viruses.

Purpose of the Study:

  • To engineer a synthetic defective interfering (DI) genome of SARS-CoV-2.
  • To assess the replication kinetics and interference potential of the synthetic DI SARS-CoV-2 genome.
  • To evaluate the therapeutic potential of DI genomes as an antiviral strategy.

Main Methods:

  • Construction of a synthetic defective interfering genome of SARS-CoV-2 lacking protein-coding genes.
  • Co-infection experiments in cell culture with synthetic DI SARS-CoV-2 and wild-type SARS-CoV-2.
  • Quantification of viral RNA and viral load to assess replication and interference.

Main Results:

  • The synthetic DI SARS-CoV-2 genome replicated three times faster than wild-type SARS-CoV-2 in co-infected cells.
  • Viral load in co-infected cells was reduced by 50% within 24 hours.
  • Efficient transmission of the synthetic genome suggests the location of the SARS-CoV-2 packaging signal.

Conclusions:

  • Synthetic DI SARS-CoV-2 genomes can efficiently replicate and interfere with wild-type virus.
  • DI genomes represent a promising self-promoting antiviral therapy strategy.
  • Further research into DI genome packaging signals could optimize therapeutic development.